Retatrutide (Reta)
A “triple agonist” peptide (targeting GLP-1, GIP, and Glucagon receptors). In clinical research, it
is analyzed for its synergistic effects on insulin secretion, gastric emptying, and thermogenesis
to study its impact on obesity and non-alcoholic fatty liver disease (NAFLD).
Be the first to review “RETATRUTIDE 20MG” Cancel reply






Reviews
There are no reviews yet.